Anti-Embolism Stockings Market

Anti-Embolism Stockings Market Outlook (2022 to 2032)

The Global Anti-Embolism Stockings Market stood at US$ 682.2 million in 2021 and is expected to reach US$ 1.2 billion by the end of 2032, expanding steadily at a CAGR of 5.2%.

When an object, such as a blood clot or bubble of air, blocks an artery, it can cause an embolism. Since organs and tissues require oxygen that is delivered through the bloodstream, this blockage can have serious consequences. Anti-embolism stockings have been shown to decrease the cross-sectional area of the limb, increase the velocity of venous flow, decrease vein wall dilation, and enhance valvular function. This can effectively counteract hypertension caused by venous issues.

• According to Persistence Market Research, calf-length stockings account for a leading market share of 64.3%.

Using anti-embolism stockings reduce the risk of deep vein thrombosis (DVT). Like compression stockings, they offer gradual compression to the legs. These stockings are intended for patients who are bedridden and do not meet the technical requirements for use as outpatients.

• Sales of anti-embolism stockings accounted for 22.7% share of the global compression therapy market in 2021.

Sales Analysis of Anti-Embolism Stockings (2017 to 2021) Vs. Market Estimates (2022 to 2032)

Worldwide sales of anti-embolism stockings increased at a CAGR of 3.6% from 2017 to 2021 owing to a rise in the elderly population.

Increasing prevalence of chronic diseases and technological advancements in the medical field are boosting sales of anti-embolism stockings. Age greatly increases the risk of venous thromboembolism. Improved healthcare facilities and increased life expectancy are factors causing a rise in the elderly population.

• According to the World Health Organization, between 2015 and 2050, the proportion of the world's population over 60 years old is projected to increase from 12% to 22%, indicating a global trend toward an aging population. In addition, the prevalence of chronic diseases such as cancer, heart disease, and diabetes has increased, leading to the development of various therapeutic approaches to manage these conditions.

As a result, advancements in healthcare technology are anticipated to propel the demand for global anti-embolism stockings.

Furthermore, the growing trend towards a sedentary lifestyle, which can lead people to be overweight and develop heart problems, is also contributing to the sales of anti-embolism stockings. Obesity increases the risk of deep vein thrombosis (DVT) due to stagnant or slow blood flow through the veins.

This increased risk of thrombosis and clot formation is a consequence of excess weight. Although once thought of as a problem primarily in high-income nations, obesity is now becoming more prevalent in middle- and low-income countries, particularly in urban areas.

Demand for anti-embolism stockings is expected to increase at a CAGR of 5.2% from 2022 to 2032.

What Opportunities Await Manufacturers of Anti-Embolism Stockings?

Major market players are focusing on integrating sensors into anti-embolism stockings to increase their effectiveness. Market players are also focusing on developing non-pneumatic shock-absorbing compression garments as an effective intervention for intradialytic hypotension.

Additionally, cancer patients are provided with pneumatic compression devices for the treatment of venous thromboembolism. The use of anti-embolism stockings for cancer patients is not a defined market in the current scenario, but it appears opportunistic in terms of growth due to affordability and ease of use.

What are the Factors Restraining the Demand Growth for Anti-Embolism Stockings?

Improper use of anti-embolism stockings can lead to complications and suboptimal medical outcomes, which can result in dissatisfaction among patients and customers. While it may seem easy to put on these stockings, incorrect use can lead to significant issues, particularly in elderly, malnourished patients, and those with thin or fragile skin. Skin cracks are a common issue that can arise from improperly worn stockings, which can impede the growth of this market.

In addition, manufacturers of medical anti-embolism stockings must adhere to strict guidelines to ensure optimal therapeutic efficacy, product reliability, and patient comfort. Patients with fragile skin, venous ulcers, or other wounds may experience friction and irritation from the garment, which can limit the range of possible design ideas. Patient safety is a crucial consideration in the design process. Maintaining consistent and repeatable pressure application during use is a significant challenge for anti-embolism stockings due to the limited size of most compression garments.

Thus, the lack of standardization in the manufacturing process, inadequate attention to promotional campaigns for non-medical use, and the effect of the material on product properties are limiting factors for the sales of anti-embolism stockings. These factors collectively have a negative impact on the developmental growth of the market.

Country-wise Insights

Will Demand for Anti-Embolism Stockings Increase in the United States?

The United States accounted for 87.8% share of the North American anti-embolism stockings market in 2021.

The increasing geriatric population and rising prevalence of blood-related diseases have contributed to the growing demand for anti-embolism stockings in the United States.

• According to the American Society of Hematology, approximately 1 to 2 in every 1,000 people suffer from venous thromboembolism in the United States each year, representing a significant opportunity for manufacturers of anti-embolism stockings in the country.

Furthermore, the increase in online sales of anti-embolism stockings presents additional opportunities for market growth in the United States.

• According to a recent assessment by the Centers for Disease Control and Prevention (CDC) in 2020, approximately 900,000 people in the United States may be suffering from deep vein thrombosis due to sedentary lifestyles. Furthermore, 10% to 30% of the population with deep vein thrombosis is expected to die within a month of diagnosis. This insight is a primary driver for the demand for anti-embolism stockings.

What is the Demand Outlook for Anti-Embolism Stockings in the United Kingdom?

Demand for anti-embolism stockings in the United Kingdom is expected to advance at a CAGR of 4.9% from 2022 to 2032. The country occupied 22% of the European market share in 2021.

In the United Kingdom, the growing awareness of health and advances in orthopedic technologies have led to increased use of anti-embolism stockings. Additionally, increased awareness of the presence and benefits of anti-embolism stockings has contributed to the rise in demand.

Online advertising of these stockings and their effectiveness in treating venous disease has also played a significant role in enabling consumers to make informed decisions based on their needs, leading to a shift away from traditional stockings and bandages towards anti-embolism stockings. As a result of these advances in the medical industry, demand for anti-embolism stockings is growing.

What Makes India a Lucrative Market for Manufacturers of Anti-Embolism Stockings?

India enjoyed 33.2% share of the South Asian market in 2021 and the demand for these stockings in the country is projected to increase at a CAGR of 4.3% through 2032.

In India, the increasing prevalence of deep vein thrombosis (DVT) and other blood clotting disorders is generating high demand for anti-embolism stockings. All these factors make India a lucrative market for manufacturers of anti-embolism stockings.

Category-wise Insights

Which Anti-Embolism Stocking Type Accounts for Higher Sales?

Demand for calf-length stockings is expected to advance at a CAGR of 4.9% through 2032. The segment accounted for a leading market share of 64.3% in 2021.

Calf-length anti-embolism stockings are a highly preferred product segment due to their superior attributes such as comfort, affordability, and safety, in comparison to thigh-length anti-embolism stockings. As a result, this segment has gained considerable popularity among consumers.

Which Demography of Anti-embolism Stockings is Largely in Focus Globally?

Anti-embolism stockings for men account for 63.1% of the market, and their sales are anticipated to progress at a CAGR of 5.4% from 2022 to 2032. This segment has a higher market share due to the higher likelihood of men being overweight or obese. Studies have shown that the prevalence of overweight and obese men is higher than that of women in certain regions.

Competitive Landscape

The market for anti-embolism stockings is highly fragmented due to the presence of multiple competitors. To maintain their position in the market, major players are implementing various strategies. They are expanding their operations into emerging regions, developing new and improved products, and improving their sales channels through online advertising. These efforts are aimed at strengthening their market presence.

Additionally, key market players are adopting the strategy of acquiring small and medium-sized players to solidify their position in the market.

• In May 2019, 3M Company entered into a decisive contract to acquire Acelity Inc. and its KCI subsidiaries globally to expand its market presence and product portfolio.
• Knit-Rite Inc. and its branch Therafirm, which is specialized in delivering compression items including compression socks, were acquired by Thuasne SAS in January 2021, a well-known medical device maker in Europe.

Anti-Embolism Stockings Industry Report Scope

Anti-Embolism Stockings Industry Research Segmentation

By Product:

• Calf-length
• Thigh-length

By Demography:

• Men
• Women

By End User:

• Ambulatory Patients
• Post-operative Patients
• Pregnant Women
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

To know more about delivery timeline for this report Contact Sales